Sign inJoin waitlistJoin the waitlist

LS

Lon Schneider

Professor of Psychiatry and Behavioral Sciences · University of Southern California/Los Angeles General Medical Center

Credentials: · ·

History

University of Southern California/Los Angeles General Medical Center
Present

Psychiatry
1979–1983

Research

Dementia prevention, intervention, and care
Review · The Lancet · 2017 · 4,153 citations
Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission
The Lancet · 2024 · 3,038 citations
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
The Lancet Neurology · 2014 · 2,536 citations

CL
Constantine Lyketsos
40 papers
Pierre Tariot
36 papers
Helena Chui
34 papers
Anton Porsteinsson
32 papers
Jacobo Mintzer
29 papers
Paul Aisen
28 papers
Paul Rosenberg
25 papers
Jeffrey Cummings
24 papers
PR
Peter Rabins
22 papers
Daniel Weintraub
21 papers
Rachelle Doody
21 papers
BP
Bruce Pollock
20 papers

Grants

FDA Approved IND 29644: Multicenter Phase 1 Trial to Evaluate Safety and Immunogenicity of Preventive Tau Vaccine, AV-1980R/A, in Cognitively Unimpaired Preclinical AD Participants.
National Institute on Aging · R01
PI · $10.2M · Institute for Molecular Medicine
2025–2030
Alzheimer's Disease Research Centers
National Institute on Aging · P30
Project lead · $5.5M · University of Southern California
2020–2030
Allopregnanolone as Regenerative Therapeutic for Alzheimer's: Phase 2 Clinical Trial
National Institute on Aging · R01
PI · $37.2M · University of Arizona
2019–2027
Safety/Tolerability/Immunogenicity of First-in-Human Aβ DNA Vaccine, AV-1959D Phase 1 Trials in Early-Stage AD Subjects: Based on IND18953 Cleared by FDA.
National Institute on Aging · R01
PI · $12.4M · Institute for Molecular Medicine
2022–2027

Clinical trials

Allopregnanolone Regenerative Therapeutic for Mild Alzheimer's Disease
Principal investigator · Active not recruiting · Phase 2
University of Arizona
2023–2027
Allopregnanolone Regenerative Therapeutic for Early Alzheimer's Disease: Intramuscular Study
Principal investigator · Terminated · Phase 1
University of Arizona
2019–2022
Allopregnanolone for Mild Cognitive Impairment Due to Alzheimer's Disease or Mild AD
Principal investigator · Completed · Phase 1
University of Southern California
2014–2018
Phytoserms for Menopause Symptoms and Age-Associated Memory Decline
Principal investigator · Completed
University of Southern California
2012–2015